Amarin Corp Plc (AMRN)

[ziploc_1]

NS....Amarin is a competitor of generic Vascepa companies...If Amarin would just leave the U.S. market to them, they would have 100% OF THE icosapentethyl sales in the U.S....rather than just the 50% that they now have...through their infringement on Amarin's CVD patent.

Anything the generic companies can do to hurt Amarin, helps themselves....They would like it if they could induce Amarin to just retreat to the EU and leave the U.S. market to them entirely...Even if/when the generic Cos. lose their Sherman act lawsuits, they can still damage tiny Amarin by having them deplete their cash by instigating meritless law suits against Amarin.